Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 396

1.

SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients.

Gurbuz I, Ferralli J, Roloff T, Chiquet-Ehrismann R, Asparuhova MB.

Mol Cancer. 2014 Feb 5;13:22. doi: 10.1186/1476-4598-13-22.

2.

Mechanism of irradiation-induced mammary cancer metastasis: A role for SAP-dependent Mkl1 signaling.

Asparuhova MB, Secondini C, Rüegg C, Chiquet-Ehrismann R.

Mol Oncol. 2015 Oct;9(8):1510-27. doi: 10.1016/j.molonc.2015.04.003. Epub 2015 Apr 30.

3.

The transcriptional regulator megakaryoblastic leukemia-1 mediates serum response factor-independent activation of tenascin-C transcription by mechanical stress.

Asparuhova MB, Ferralli J, Chiquet M, Chiquet-Ehrismann R.

FASEB J. 2011 Oct;25(10):3477-88. doi: 10.1096/fj.11-187310. Epub 2011 Jun 24.

4.

Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.

Calvo A, Catena R, Noble MS, Carbott D, Gil-Bazo I, Gonzalez-Moreno O, Huh JI, Sharp R, Qiu TH, Anver MR, Merlino G, Dickson RB, Johnson MD, Green JE.

Oncogene. 2008 Sep 11;27(40):5373-84. doi: 10.1038/onc.2008.155. Epub 2008 May 26.

5.

RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.

Oh JJ, Taschereau EO, Koegel AK, Ginther CL, Rotow JK, Isfahani KZ, Slamon DJ.

Lung Cancer. 2010 Dec;70(3):253-62. doi: 10.1016/j.lungcan.2010.02.012. Epub 2010 Mar 24.

PMID:
20338664
6.

Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.

Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W, Yuan Z.

BMC Cancer. 2009 Apr 1;9:102. doi: 10.1186/1471-2407-9-102.

7.

[Prognostic molecular classification of breast cancers based on gene expression profiling].

Feng YM, Li XQ, Sun BC, Gao XC, Gu L, Niu Y, Hao XS.

Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):900-6. Chinese.

PMID:
17533740
8.

Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.

Cen B, Selvaraj A, Burgess RC, Hitzler JK, Ma Z, Morris SW, Prywes R.

Mol Cell Biol. 2003 Sep;23(18):6597-608.

9.

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.

Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C.

Breast Cancer Res. 2009;11(1):R1. doi: 10.1186/bcr2215. Epub 2009 Jan 5.

10.

The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1.

Muehlich S, Hampl V, Khalid S, Singer S, Frank N, Breuhahn K, Gudermann T, Prywes R.

Oncogene. 2012 Aug 30;31(35):3913-23. doi: 10.1038/onc.2011.560. Epub 2011 Dec 5.

PMID:
22139079
11.

Bridging cancer biology with the clinic: relative expression of a GRHL2-mediated gene-set pair predicts breast cancer metastasis.

Yang X, Vasudevan P, Parekh V, Penev A, Cunningham JM.

PLoS One. 2013;8(2):e56195. doi: 10.1371/journal.pone.0056195. Epub 2013 Feb 18.

12.

Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231.

Morini M, Astigiano S, Gitton Y, Emionite L, Mirisola V, Levi G, Barbieri O.

BMC Cancer. 2010 Nov 25;10:649. doi: 10.1186/1471-2407-10-649.

13.

ERBB2 overexpression triggers transient high mechanoactivity of breast tumor cells.

Martin M, Müller K, Cadenas C, Hermes M, Zink M, Hengstler JG, Käs JA.

Cytoskeleton (Hoboken). 2012 May;69(5):267-77. doi: 10.1002/cm.21023. Epub 2012 Apr 12.

PMID:
22407943
14.

Semaphorin-plexin signalling genes associated with human breast tumourigenesis.

Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.

Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2.

PMID:
21925246
15.

Megakaryoblastic leukemia factor-1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells.

Du KL, Chen M, Li J, Lepore JJ, Mericko P, Parmacek MS.

J Biol Chem. 2004 Apr 23;279(17):17578-86. Epub 2004 Feb 17.

16.

JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.

Lee YF, Miller LD, Chan XB, Black MA, Pang B, Ong CW, Salto-Tellez M, Liu ET, Desai KV.

Breast Cancer Res. 2012 May 23;14(3):R85.

17.

Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells--interplay of ErbB and IGF1 signalling through IGFBP3 regulation.

Worthington J, Bertani M, Chan HL, Gerrits B, Timms JF.

BMC Cancer. 2010 Sep 14;10:490. doi: 10.1186/1471-2407-10-490.

18.

Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer.

Lee HJ, Liu H, Goodman C, Ji Y, Maehr H, Uskokovic M, Notterman D, Reiss M, Suh N.

Biochem Pharmacol. 2006 Jul 28;72(3):332-43. Epub 2006 May 5.

PMID:
16737686
19.

Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.

Alexopoulou AN, Leao M, Caballero OL, Da Silva L, Reid L, Lakhani SR, Simpson AJ, Marshall JF, Neville AM, Jat PS.

Breast Cancer Res. 2010;12(4):R51. doi: 10.1186/bcr2610. Epub 2010 Jul 19.

20.

Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression.

Zu X, Ma J, Liu H, Liu F, Tan C, Yu L, Wang J, Xie Z, Cao D, Jiang Y.

Breast Cancer Res. 2011 Mar 10;13(2):R26. doi: 10.1186/bcr2843.

Items per page

Supplemental Content

Write to the Help Desk